Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48.73% | -27.69% | 693,312.15 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 372,168.87 | 3.21% | 2.71% |
|
NYSE:MRK
Merck
|
131.19 | -10.02% | 3.18% | 332,278.86 | 2.35% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.64 | 8.42% | 38.65% | 162,291.22 | 5.81% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
445.21 | -2.11% | 5.64% | 114,887.95 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
982.29 | -29.59% | -23.59% | 105,974.85 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.44% | 13.54% |
|
NYSE:ZTS
Zoetis
|
174.06 | 27.11% | 42.85% | 79,422.73 | 0.99% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
149.40 | 0% | 0% | 18,897.87 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.25 | 82.77% | 110.35% | 17,962.7 | 3.3% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
10.98 | 5.13% | 15.66% | 13,324.53 | 4.36% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
274.26 | -10.71% | -1.33% | 11,803.71 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
55.37 | -57.27% | -6.76% | 10,100.49 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
59.53 | 0% | 0% | 6,707.63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
37.31 | -,156.68% | -,149.23% | 5,756.54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
155.83 | -9.31% | -0.59% | 5,026.29 | 0.5% | 5.85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
220.06 | 0% | 0% | 4,409.78 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
29.83 | 35.17% | 58.31% | 4,186.4 | 3.67% | -10.73% |
|
NasdaqGS:NEOG
Neogen
|
13.54 | 133.55% | 233.03% | 2,692.43 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
28.09 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
